| Drug Type Small molecule drug | 
| Synonyms 17-Alpha estradiol, 17-α estradiol, 17alpha-Estradiol + [6] | 
| Target | 
| Action agonists | 
| Mechanism ERs agonists(Estrogen receptors agonists) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication | 
| Originator Organization- | 
| Active Organization- | 
| Inactive Organization | 
| License Organization- | 
| Drug Highest PhaseApproved | 
| First Approval Date- | 
| Regulation- | 
| Molecular FormulaC18H24O2 | 
| InChIKeyVOXZDWNPVJITMN-SFFUCWETSA-N | 
| CAS Registry57-91-0 | 
| KEGG | Wiki | ATC | Drug Bank | 
|---|---|---|---|
| D07121 | Alfatradiol | 
| Indication | Country/Location | Organization | Date | 
|---|---|---|---|
| Alopecia | - | - | - | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Alzheimer Disease | Phase 1 | United States  | - | - | 
| Friedreich Ataxia | Phase 1 | United States  | - | - | 
| Parkinson Disease | Phase 1 | United States  | - | - | 
| Retinitis Pigmentosa | Discovery | United States  | - | 
| Phase 4 | 35 | rbavivmokk(pinrukpolp) = vncbtrlnsv zhiasnguia  (bofhjbviof, 0.345) View more | - | 23 Sep 2021 | 





